Trials / Sponsors / Baodong Qin
Baodong Qin
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC NSCLC Stage IV, EGFR T790M-negative, Anlotinib | — | 2019-09-01 |
| Unknown | Effect of Chemotherapy on TMB in NSCLC Chemotherapy Effect, Immunotherapy, Tumor Mutation Burden | — | 2018-09-01 |
| Unknown | Effect of Chemotherapy on PD-L1 in NSCLC Chemotherapy, Immunotherapy, PD-L1 | — | 2018-09-01 |
| Unknown | Efficacy and Safety of Precision Therapy in Refractory Tumor Rare Tumor, Refractory Tumor | Phase 2 | 2017-01-01 |